Peter Meldgaard

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

Johan Vansteenkiste, Lucio Crinò, Christophe Dooms et al. · Annals of Oncology · 2014 · 492 citations · Full text

Advanced Lung Disease, Medicine, Cancer Management +7

Exosomal Proteins as Diagnostic Biomarkers in Lung Cancer

Birgitte Sandfeld‐Paulsen, Kristine Raaby Jakobsen, Rikke Bæk et al. · Journal of Thoracic Oncology · 2016 · 301 citations · Full text

Exosomes, Diagnostic Biomarkers, Medicine +8

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

K.M. Kerr, L. Bubendorf, Martin J. Edelman et al. · Annals of Oncology · 2014 · 286 citations · Full text

Molecular Biomarkers, Prognostic Biomarkers, Oncology +10

Exosomal proteins as prognostic biomarkers in non‐small cell lung cancer

Birgitte Sandfeld‐Paulsen, Ninna Aggerholm‐Pedersen, Rikke Bæk et al. · Molecular Oncology · 2016 · 248 citations · Full text

Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor‐sensitizing and resistance mutations in the plasma DNA of patients with advanced non–small cell lung cancer during treatment with erlotinib

Boe Sandahl Sørensen, Lin Wu, Wen Wei et al. · Cancer · 2014 · 192 citations · Full text